Cochrane Abstracts
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV‐negative people at risk of active TB
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rifamycins (rifampicin, Rifabutin and Rifapentine) Compared to Isoniazid for Preventing Tuberculosis in HIV‐negative People at Risk of Active TB." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433809/all/Rifamycins__rifampicin__rifabutin_and_rifapentine__compared_to_isoniazid_for_preventing_tuberculosis_in_HIV‐negative_people_at_risk_of_active_TB.
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV‐negative people at risk of active TB. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433809/all/Rifamycins__rifampicin__rifabutin_and_rifapentine__compared_to_isoniazid_for_preventing_tuberculosis_in_HIV‐negative_people_at_risk_of_active_TB. Accessed April 20, 2026.
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV‐negative people at risk of active TB. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433809/all/Rifamycins__rifampicin__rifabutin_and_rifapentine__compared_to_isoniazid_for_preventing_tuberculosis_in_HIV‐negative_people_at_risk_of_active_TB
Rifamycins (rifampicin, Rifabutin and Rifapentine) Compared to Isoniazid for Preventing Tuberculosis in HIV‐negative People at Risk of Active TB [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433809/all/Rifamycins__rifampicin__rifabutin_and_rifapentine__compared_to_isoniazid_for_preventing_tuberculosis_in_HIV‐negative_people_at_risk_of_active_TB.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV‐negative people at risk of active TB
ID - 433809
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433809/all/Rifamycins__rifampicin__rifabutin_and_rifapentine__compared_to_isoniazid_for_preventing_tuberculosis_in_HIV‐negative_people_at_risk_of_active_TB
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
